openPR Logo
Press release

Electroencephalographs Market - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

10-11-2017 04:40 PM CET | Health & Medicine

Press release from: Electroencephalographs Market

Electroencephalographs Market - Global Industry Insights,

Electroencephalography is used to record electrical activity of the brain using electrophysiological monitoring method, which is typically a noninvasive method where electrodes are placed along the scalp. Electroencephalographs measures voltage fluctuations resulting from ionic current within the neurons of the brain over a period of time. Also called brain waves, neural oscillations are observed in electroencephalography. Electroencephalography is most often used in diagnosis of epilepsy, which is a neurological disorder. Furthermore, electroencephalographs are used to diagnose sleep disorders, encephalopathies, coma and brain death. Electroencephalography performs first line diagnosis of tumors, stroke and brain death disorders. Moreover, electroencephalographs are valuable tools for research diagnosis, especially when millisecond-range temporal resolution in required which is not possible with CT or MRI. Research in field of neuroscience, psychophysiological, neurolinguistics, cognitive psychology and cognitive science.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/505

Furthermore, Alzheimer’s disease is also diagnosed by electroencephalograph, which is a disorder that affects the brain. Certain psychoses and sleep disorder called narcolepsy are also diagnosed by electroencephalographs. Electroencephalographs are also used to determine electrical activity of the brain overall is case of trauma, drug intoxication or extent of brain damage. Blood flow in brain during surgical process is also monitored by electroencephalographs.

Electroencephalographs Market Taxonomy

By Product Type

Patient Monitors
Transmitters
By Application

Intensive Care
Infant
By End User

Hospitals
Research Laboratories

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/505

Rising incidence of mental illness is expected to fuel the growth of electroencephalographs market in the near future

The rise in incidence of brain disorders such as Alzheimer’s disease, epilepsy and psychiatric illness has significantly increased the market of electroencephalographs. According to the annual report of Alzheimer’s Association (AA), it was estimated that 5.4 million people in the U.S. suffer from Alzheimer’s disease in 2012 and by 2050, it is estimated that between 11 million to 16 million people in the U.S. will suffer from Alzheimer’s disease, with one new case appearing every 33 seconds. Moreover, Alzheimer’s disease International showed that 35.6 million people suffered from Alzheimer’s disease worldwide in 2010. Moreover, according to WHO, published facts list updated on Feb 2017 50 million suffer from epilepsy which fuels the market of electroencephalographs. Furthermore, according to WHO, depression was the third-leading cause of disease burden worldwide, where mental and behavioral disorder contributed 7.4% and neurological disorder 3% in 2010 which determines the increase in market of electroencephalographs.

Regional growth engines of electroencephalographs market

Mental illness is most prominently observed in the North America region. Around 1 in 5 adults in U.S. that is 43.8 million, or 18.5% suffered from some form of mental illness in 2015. This creates a highly conducive environment for growth of the electroencephalographs market in the country. Moreover, the incidence of mental illness has increased in Asia, especially in India and China. According to Journal of Indian Academy of Neurology, 70 million people were suffering from epilepsy worldwide, whereas India reported 12 million of people suffering from epilepsy which contributed one-sixth of the global burden in the year 2014. The European region also offers a huge market for electroencephalographs due to rise in awareness of neurological disorders and increase in purchasing power.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/electroencephalographs-market-505

Key players supporting the growth of electroencephalographs market

Manufactures are focusing on offering advanced features to electroencephalographs at affordable prices to gain a competitive edge in the market. Key players operating in the global electroencephalograph market include HEYER Medical AG, Medicom MTD, Draeger, Inc., Natus Medical Incorporated, Masimo, NeuroWave Systems Inc., Brain Products, elmiko medical, CamNtech Ltd, Danmeter, Neurosoft and MT MonitorTechnik GmbH & CO.KG.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Electroencephalographs Market - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025 here

News-ID: 768616 • Views:

More Releases for Alzheimer’s

Increasing Global Prevalence of Alzheimer’s and Improvising Regulatory Scenari …
Alzheimer’s disease is a neurodegenerative disorder that causes slow decline in abilities such as thinking, reasoning, and routine daily activities, alongside memory loss. This may lead to planning or solving problems, poor judgment, lack of social activities, and personality and mood changes, which are considered the most common symptoms of Alzheimer’s disease. Symptoms of Alzheimer’s disease generally begin to appear in patients in their mid-sixties. As per World Alzheimer’s report,
Media Advisory: Alzheimer’s Disease Resource Center, Inc. Presents 10th Annual …
Who: Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Disease Resource Center, Inc. (ADRC) Participating Walk for Alzheimer’s teams and individuals Mickey B, Radio Personality, WGBB Radio and Master of Ceremonies Ronald McDonald The Liberty Bells, USO troupe What: Alzheimer’s Disease Resource Center, Inc. (ADRC) is presenting its 10th Annual Old Bethpage Walk for Alzheimer’s & Mexican Fiesta. There will be an opening ceremony with Mickey B, Radio Personality, WGBB Radio, as the Master of
Home Care Assistance Partners with the Alzheimer’s Association to Promote Earl …
(Palo Alto, CA – November 29, 2011) Home Care Assistance, North America’s leading provider of in-home care for seniors, announced today that, along with companies including Genworth, Starbucks, Intel and Pfizer, they are now a Champion Partner of the Alzheimer’s Early Detection Alliance (AEDA). The AEDA is a program renowned for raising Alzheimer’s awareness and promoting early detection of the disease. As a member of this important alliance, Home
Alzheimer’s Association Long Island Announces Release of Latest Report on Alzh …
Alzheimer’s Association Long Island announced the release of the most recent report about Alzheimer’s disease. “Alzheimer’s from the Frontlines: Challenges a National Alzheimer’s Plan Must Address” provides a look into the unrelenting challenges brought on by this disease by offering insights and perspectives from individuals across the country who participated in the Alzheimer’s Association’s public input process. The Association and over 70 of its chapters hosted 132 input sessions throughout
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to
Alzheimer’s Association Long Island Presents Public Input Session for National …
On August 24, Alzheimer’s Association Long Island will hold a public input session to solicit views, comments and perspectives from stakeholders in the Alzheimer’s community to assist in the development of a successful National Alzheimer’s Plan. The recommendations and comments expressed during these input sessions, taking place across the country in August, will be collected and shared this fall with officials from the U.S. Department of Health and Human Services,